SOURCE: Progressive Care Inc

Progressive Care Inc

April 11, 2016 10:34 ET

Progressive Care Signs New Agreements for Market Awareness and Web Development

MIAMI, FL--(Marketwired - April 11, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, engages web development and market awareness consultants.

On April 6, 2016, Progressive Care signed two separate agreements to increase awareness of the company and revitalize its web presence. Midam Ventures, LLC will provide market awareness and business advisory services for a term of 6 months. Mass Ventures, LLC will provide web development, digital marketing, and branding services for a period of 3 months. This period of time encompasses the revitalization of the company's web presence and enhancement on all levels of its digital marketing abilities. Under the terms of both agreements, the Company will compensate the consultants in both cash and stock over the length of the engagements.

"We are excited to begin a new chapter of modernization and development," stated S. Parikh Mars, CEO. "Over the next few months we hope that our partnerships with Midam Ventures and Mass Ventures will allow the Company to increase its visibility and roll-out brand new websites with enhanced interactive and marketing capabilities. We are thrilled that we will be able to interact with our customers, affiliates and shareholders through new, modern, and convenient media streams."

About Progressive Care

Progressive Care, Inc. (OTC PINK: RXMD), through its subsidiary PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities.

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company's expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words "anticipate," "believe," "estimate," "upcoming," "plan," "target", "intend" and "expect" and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.